

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cerebellar granule cell differentiation (GO:0021707) | 7.28937382 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.98159427 |
| 3 | regulation of synapse structural plasticity (GO:0051823) | 5.80182767 |
| 4 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.68208688 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.52454548 |
| 6 | * synaptic transmission, dopaminergic (GO:0001963) | 5.50490374 |
| 7 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.47375810 |
| 8 | * prepulse inhibition (GO:0060134) | 5.24046833 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.00488139 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.99932875 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.90944636 |
| 12 | * striatum development (GO:0021756) | 4.88849587 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.88269046 |
| 14 | vocalization behavior (GO:0071625) | 4.85471297 |
| 15 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.81346945 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.76598199 |
| 17 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.64577729 |
| 18 | locomotory exploration behavior (GO:0035641) | 4.60579454 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.53843731 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.53196262 |
| 21 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.52921452 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.52281629 |
| 23 | protein localization to synapse (GO:0035418) | 4.49181367 |
| 24 | * neuron-neuron synaptic transmission (GO:0007270) | 4.41198373 |
| 25 | auditory behavior (GO:0031223) | 4.41104515 |
| 26 | cochlea development (GO:0090102) | 4.37598171 |
| 27 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.37121254 |
| 28 | cAMP catabolic process (GO:0006198) | 4.31744717 |
| 29 | response to histamine (GO:0034776) | 4.31718659 |
| 30 | * transmission of nerve impulse (GO:0019226) | 4.25631771 |
| 31 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.23929633 |
| 32 | cell differentiation in hindbrain (GO:0021533) | 4.22420608 |
| 33 | * response to amphetamine (GO:0001975) | 4.20302713 |
| 34 | positive regulation of neurotransmitter transport (GO:0051590) | 4.20149562 |
| 35 | adenosine receptor signaling pathway (GO:0001973) | 4.19991099 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.18017254 |
| 37 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.16952125 |
| 38 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.13159290 |
| 39 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.11829388 |
| 40 | regulation of glutamate secretion (GO:0014048) | 4.11001636 |
| 41 | response to auditory stimulus (GO:0010996) | 4.09336921 |
| 42 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.09127480 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 4.07468575 |
| 44 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 4.07241834 |
| 45 | synaptic transmission, glutamatergic (GO:0035249) | 4.04433726 |
| 46 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.04092362 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03724094 |
| 48 | neurotransmitter secretion (GO:0007269) | 4.03567717 |
| 49 | sodium ion export (GO:0071436) | 4.01358059 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 4.00690465 |
| 51 | long-term memory (GO:0007616) | 3.99565163 |
| 52 | positive regulation of synapse maturation (GO:0090129) | 3.99216624 |
| 53 | serotonin metabolic process (GO:0042428) | 3.99162535 |
| 54 | * positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.98083010 |
| 55 | positive regulation of membrane potential (GO:0045838) | 3.96445274 |
| 56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.94160824 |
| 57 | * dopamine receptor signaling pathway (GO:0007212) | 3.93434255 |
| 58 | presynaptic membrane organization (GO:0097090) | 3.91986291 |
| 59 | membrane hyperpolarization (GO:0060081) | 3.91615613 |
| 60 | regulation of female receptivity (GO:0045924) | 3.90618292 |
| 61 | regulation of synaptic vesicle transport (GO:1902803) | 3.90616375 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.86181692 |
| 63 | neuron recognition (GO:0008038) | 3.85018644 |
| 64 | * behavioral response to cocaine (GO:0048148) | 3.84546745 |
| 65 | * adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.82871179 |
| 66 | cyclic nucleotide catabolic process (GO:0009214) | 3.81787919 |
| 67 | * adult walking behavior (GO:0007628) | 3.79741084 |
| 68 | regulation of postsynaptic membrane potential (GO:0060078) | 3.77725838 |
| 69 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.76798215 |
| 70 | positive regulation of synapse assembly (GO:0051965) | 3.75442726 |
| 71 | regulation of protein kinase A signaling (GO:0010738) | 3.72747250 |
| 72 | detection of calcium ion (GO:0005513) | 3.71752364 |
| 73 | female mating behavior (GO:0060180) | 3.67778130 |
| 74 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.65331522 |
| 75 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.64857855 |
| 76 | cGMP metabolic process (GO:0046068) | 3.62522452 |
| 77 | neuromuscular process controlling balance (GO:0050885) | 3.61785397 |
| 78 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.59731232 |
| 79 | negative regulation of amino acid transport (GO:0051956) | 3.56714654 |
| 80 | layer formation in cerebral cortex (GO:0021819) | 3.56675438 |
| 81 | * regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.54225930 |
| 82 | * regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.54225930 |
| 83 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.51276106 |
| 84 | cellular sodium ion homeostasis (GO:0006883) | 3.50537109 |
| 85 | neuronal action potential propagation (GO:0019227) | 3.49034343 |
| 86 | neuron cell-cell adhesion (GO:0007158) | 3.48175559 |
| 87 | proline transport (GO:0015824) | 3.44916228 |
| 88 | membrane depolarization during action potential (GO:0086010) | 3.44758253 |
| 89 | lens fiber cell development (GO:0070307) | 3.44694989 |
| 90 | dendritic spine morphogenesis (GO:0060997) | 3.44302716 |
| 91 | glutamate secretion (GO:0014047) | 3.41898895 |
| 92 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.41333053 |
| 93 | L-amino acid import (GO:0043092) | 3.40417044 |
| 94 | primary amino compound metabolic process (GO:1901160) | 3.40022646 |
| 95 | cAMP metabolic process (GO:0046058) | 3.39146352 |
| 96 | * regulation of synaptic plasticity (GO:0048167) | 3.38548354 |
| 97 | * long-term synaptic potentiation (GO:0060291) | 3.38081820 |
| 98 | mechanosensory behavior (GO:0007638) | 3.34958301 |
| 99 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.34566205 |
| 100 | negative regulation of dendrite development (GO:2000171) | 3.34071094 |
| 101 | * visual learning (GO:0008542) | 3.34054700 |
| 102 | exploration behavior (GO:0035640) | 3.32033838 |
| 103 | drinking behavior (GO:0042756) | 3.31295263 |
| 104 | membrane depolarization (GO:0051899) | 3.30991310 |
| 105 | * behavioral fear response (GO:0001662) | 3.29893238 |
| 106 | * behavioral defense response (GO:0002209) | 3.29893238 |
| 107 | regulation of neurotransmitter secretion (GO:0046928) | 3.28427507 |
| 108 | * learning (GO:0007612) | 3.27476562 |
| 109 | * regulation of neurotransmitter uptake (GO:0051580) | 3.27442835 |
| 110 | regulation of neurotransmitter levels (GO:0001505) | 3.27432719 |
| 111 | * regulation of neurotransmitter transport (GO:0051588) | 3.26939523 |
| 112 | cell communication by electrical coupling (GO:0010644) | 3.24772988 |
| 113 | neurotransmitter transport (GO:0006836) | 3.23759509 |
| 114 | neuronal ion channel clustering (GO:0045161) | 3.23363081 |
| 115 | synaptic vesicle endocytosis (GO:0048488) | 3.23338597 |
| 116 | central nervous system myelination (GO:0022010) | 3.20976637 |
| 117 | axon ensheathment in central nervous system (GO:0032291) | 3.20976637 |
| 118 | retinal cone cell development (GO:0046549) | 3.20903421 |
| 119 | asymmetric protein localization (GO:0008105) | 3.20530376 |
| 120 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18485217 |
| 121 | * visual behavior (GO:0007632) | 3.17576454 |
| 122 | regulation of synapse maturation (GO:0090128) | 3.17491541 |
| 123 | regulation of dendritic spine development (GO:0060998) | 3.16784114 |
| 124 | potassium ion homeostasis (GO:0055075) | 3.16456780 |
| 125 | * positive regulation of synaptic transmission (GO:0050806) | 3.15382689 |
| 126 | gamma-aminobutyric acid transport (GO:0015812) | 3.14570910 |
| 127 | regulation of synapse assembly (GO:0051963) | 3.13728932 |
| 128 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.11956644 |
| 129 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10876305 |
| 130 | postsynaptic membrane organization (GO:0001941) | 3.08787981 |
| 131 | innervation (GO:0060384) | 3.06651216 |
| 132 | * multicellular organismal signaling (GO:0035637) | 3.01542829 |
| 133 | relaxation of smooth muscle (GO:0044557) | 3.01356364 |
| 134 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.00910577 |
| 135 | regulation of vesicle fusion (GO:0031338) | 3.00540519 |
| 136 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.96920630 |
| 137 | cell communication involved in cardiac conduction (GO:0086065) | 2.95623346 |
| 138 | neuromuscular process (GO:0050905) | 2.90366336 |
| 139 | ephrin receptor signaling pathway (GO:0048013) | 2.88752056 |
| 140 | startle response (GO:0001964) | 2.88424355 |
| 141 | * synaptic transmission (GO:0007268) | 2.88286707 |
| 142 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.87346413 |
| 143 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.87333785 |
| 144 | * adult locomotory behavior (GO:0008344) | 2.84383791 |
| 145 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.82215696 |
| 146 | amino acid import (GO:0043090) | 2.79560722 |
| 147 | cardiac muscle adaptation (GO:0014887) | 2.79398243 |
| 148 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.79398243 |
| 149 | muscle hypertrophy in response to stress (GO:0003299) | 2.79398243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.21090261 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.92418577 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.58032458 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.20212441 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12494995 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97588459 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72280033 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.70579393 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69322442 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.64035189 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.64035189 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60589005 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55484011 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.54436518 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49555389 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47812350 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.36639173 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33791340 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33566748 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.28185565 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28080452 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.26494960 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19636302 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18903768 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12279388 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07554039 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.04223448 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03708570 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99459643 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91169444 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86085793 |
| 32 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.81611470 |
| 33 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.77726698 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70871517 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.70413526 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67363185 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55860005 |
| 38 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.54222000 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54204514 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52573884 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50435642 |
| 42 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50250686 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48274336 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46040810 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.44288421 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42525681 |
| 47 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.38543024 |
| 48 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38386262 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38128551 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31803069 |
| 51 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30589667 |
| 52 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29899645 |
| 53 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27450803 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26063543 |
| 55 | AR_19668381_ChIP-Seq_PC3_Human | 1.24116368 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21639784 |
| 57 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20890877 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19795624 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19712848 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19118509 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18593556 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16785600 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16567551 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16555720 |
| 65 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16055074 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13694733 |
| 67 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.13329001 |
| 68 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13277717 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12629643 |
| 70 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11698606 |
| 71 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.09204459 |
| 72 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09136340 |
| 73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09009234 |
| 74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08087920 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07604645 |
| 76 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05875161 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05139498 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04976606 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04854400 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03227123 |
| 81 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02723513 |
| 82 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02188160 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01448955 |
| 84 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01293506 |
| 85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01047114 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99955652 |
| 87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99955652 |
| 88 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.99725474 |
| 89 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99301713 |
| 90 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99254005 |
| 91 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98934915 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98090930 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98027136 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97753622 |
| 95 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97722532 |
| 96 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96818963 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95991789 |
| 98 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95328839 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95074846 |
| 100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95062052 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94944766 |
| 102 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94680935 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94394398 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93967162 |
| 105 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93637997 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93563144 |
| 107 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93439026 |
| 108 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.92667473 |
| 109 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92494965 |
| 110 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91884857 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91495119 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91374107 |
| 113 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91153459 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91131414 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91101647 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90625689 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90065755 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89927440 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89103803 |
| 120 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87489746 |
| 121 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87390614 |
| 122 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87058999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 8.94548500 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.36616647 |
| 3 | MP0003880_abnormal_central_pattern | 4.16904518 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.91088135 |
| 5 | MP0009745_abnormal_behavioral_response | 3.61551473 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.37834117 |
| 7 | MP0001529_abnormal_vocalization | 3.05658593 |
| 8 | MP0002064_seizures | 2.92562188 |
| 9 | MP0009046_muscle_twitch | 2.90432290 |
| 10 | MP0001486_abnormal_startle_reflex | 2.82626872 |
| 11 | MP0004270_analgesia | 2.78032890 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.71954862 |
| 13 | MP0002272_abnormal_nervous_system | 2.53099420 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.42751357 |
| 15 | MP0001984_abnormal_olfaction | 2.34432631 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.17673001 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.14906951 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 2.12733285 |
| 19 | MP0000566_synostosis | 2.08315470 |
| 20 | MP0001188_hyperpigmentation | 2.03171495 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.01831132 |
| 22 | MP0005386_behavior/neurological_phenoty | 1.96574949 |
| 23 | MP0004924_abnormal_behavior | 1.96574949 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.93848466 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.93445431 |
| 26 | MP0002090_abnormal_vision | 1.79347286 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.73931289 |
| 28 | MP0008569_lethality_at_weaning | 1.71269547 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.65331282 |
| 30 | MP0001970_abnormal_pain_threshold | 1.60138961 |
| 31 | MP0005409_darkened_coat_color | 1.57696393 |
| 32 | MP0003879_abnormal_hair_cell | 1.55296235 |
| 33 | MP0002736_abnormal_nociception_after | 1.53108223 |
| 34 | MP0003136_yellow_coat_color | 1.51997706 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.50374482 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.50067376 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.46737576 |
| 38 | MP0002184_abnormal_innervation | 1.46152984 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.42181753 |
| 40 | MP0003938_abnormal_ear_development | 1.28897074 |
| 41 | MP0008872_abnormal_physiological_respon | 1.28853705 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.23341630 |
| 43 | MP0001905_abnormal_dopamine_level | 1.22844908 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.22670531 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.21593346 |
| 46 | MP0005394_taste/olfaction_phenotype | 1.21133198 |
| 47 | MP0005499_abnormal_olfactory_system | 1.21133198 |
| 48 | MP0001346_abnormal_lacrimal_gland | 1.21007361 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.17355173 |
| 50 | MP0004885_abnormal_endolymph | 1.16900241 |
| 51 | MP0000955_abnormal_spinal_cord | 1.16839173 |
| 52 | MP0003633_abnormal_nervous_system | 1.14710476 |
| 53 | MP0008874_decreased_physiological_sensi | 1.14243903 |
| 54 | MP0001177_atelectasis | 1.13950871 |
| 55 | MP0004233_abnormal_muscle_weight | 1.12562393 |
| 56 | MP0003075_altered_response_to | 1.10046329 |
| 57 | MP0000026_abnormal_inner_ear | 1.09103363 |
| 58 | MP0000778_abnormal_nervous_system | 1.08381191 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.08089927 |
| 60 | MP0003122_maternal_imprinting | 1.06406455 |
| 61 | MP0002229_neurodegeneration | 1.05874573 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.05548659 |
| 63 | MP0003329_amyloid_beta_deposits | 1.04023756 |
| 64 | MP0004085_abnormal_heartbeat | 1.00800542 |
| 65 | MP0009379_abnormal_foot_pigmentation | 0.98322432 |
| 66 | MP0008961_abnormal_basal_metabolism | 0.98288839 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.97382473 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 0.96905446 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 0.91858839 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.91693760 |
| 71 | MP0006292_abnormal_olfactory_placode | 0.90639669 |
| 72 | MP0004142_abnormal_muscle_tone | 0.90451766 |
| 73 | MP0002653_abnormal_ependyma_morphology | 0.90140261 |
| 74 | MP0003632_abnormal_nervous_system | 0.88695608 |
| 75 | MP0003787_abnormal_imprinting | 0.87541280 |
| 76 | MP0002152_abnormal_brain_morphology | 0.85872870 |
| 77 | MP0003011_delayed_dark_adaptation | 0.85672968 |
| 78 | MP0003631_nervous_system_phenotype | 0.84853126 |
| 79 | MP0005253_abnormal_eye_physiology | 0.84442054 |
| 80 | MP0005248_abnormal_Harderian_gland | 0.81162922 |
| 81 | MP0004043_abnormal_pH_regulation | 0.80323212 |
| 82 | MP0005535_abnormal_body_temperature | 0.78647180 |
| 83 | MP0004742_abnormal_vestibular_system | 0.78090103 |
| 84 | MP0000579_abnormal_nail_morphology | 0.77629567 |
| 85 | MP0003137_abnormal_impulse_conducting | 0.76795369 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.76570867 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.76391906 |
| 88 | MP0004036_abnormal_muscle_relaxation | 0.75968403 |
| 89 | MP0000751_myopathy | 0.75917829 |
| 90 | MP0008877_abnormal_DNA_methylation | 0.73762221 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.71447668 |
| 92 | MP0002928_abnormal_bile_duct | 0.70760633 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.68927784 |
| 94 | MP0003861_abnormal_nervous_system | 0.68709375 |
| 95 | MP0005195_abnormal_posterior_eye | 0.67861135 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.66117998 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.65828800 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.65758189 |
| 99 | MP0000462_abnormal_digestive_system | 0.64976747 |
| 100 | MP0004858_abnormal_nervous_system | 0.64670131 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.64162443 |
| 102 | MP0004510_myositis | 0.63885632 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.63832405 |
| 104 | MP0000920_abnormal_myelination | 0.62336191 |
| 105 | MP0005623_abnormal_meninges_morphology | 0.61850204 |
| 106 | MP0003634_abnormal_glial_cell | 0.61828658 |
| 107 | MP0003690_abnormal_glial_cell | 0.61014694 |
| 108 | MP0010030_abnormal_orbit_morphology | 0.60348091 |
| 109 | MP0004084_abnormal_cardiac_muscle | 0.59926752 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.58112169 |
| 111 | MP0009250_abnormal_appendicular_skeleto | 0.57159213 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.56931733 |
| 113 | MP0000383_abnormal_hair_follicle | 0.56573637 |
| 114 | MP0001664_abnormal_digestion | 0.55896232 |
| 115 | MP0004147_increased_porphyrin_level | 0.54818316 |
| 116 | MP0002089_abnormal_postnatal_growth/wei | 0.54045435 |
| 117 | MP0010770_preweaning_lethality | 0.53795972 |
| 118 | MP0002082_postnatal_lethality | 0.53795972 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.52308767 |
| 120 | MP0005620_abnormal_muscle_contractility | 0.51043722 |
| 121 | MP0008789_abnormal_olfactory_epithelium | 0.50697232 |
| 122 | MP0003283_abnormal_digestive_organ | 0.50669221 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.48631702 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.48144396 |
| 125 | MP0001485_abnormal_pinna_reflex | 0.47008730 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.46416802 |
| 127 | MP0002234_abnormal_pharynx_morphology | 0.45357657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 8.19868168 |
| 2 | Focal motor seizures (HP:0011153) | 7.51737800 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.76609061 |
| 4 | Focal seizures (HP:0007359) | 5.33979892 |
| 5 | Split foot (HP:0001839) | 4.89530951 |
| 6 | Oligodactyly (hands) (HP:0001180) | 4.79149557 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.61068083 |
| 8 | Synostosis involving the elbow (HP:0003938) | 4.43387362 |
| 9 | Humeroradial synostosis (HP:0003041) | 4.43387362 |
| 10 | Annular pancreas (HP:0001734) | 4.39302856 |
| 11 | Febrile seizures (HP:0002373) | 4.36516114 |
| 12 | Central scotoma (HP:0000603) | 4.16208883 |
| 13 | Torticollis (HP:0000473) | 4.15715388 |
| 14 | Absence seizures (HP:0002121) | 4.08446333 |
| 15 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.94293770 |
| 16 | Dysdiadochokinesis (HP:0002075) | 3.89347551 |
| 17 | Visual hallucinations (HP:0002367) | 3.88326052 |
| 18 | Dialeptic seizures (HP:0011146) | 3.77253258 |
| 19 | Hypoplastic pelvis (HP:0008839) | 3.72134032 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.69743512 |
| 21 | Resting tremor (HP:0002322) | 3.69344132 |
| 22 | Severe visual impairment (HP:0001141) | 3.68534708 |
| 23 | Dysmetric saccades (HP:0000641) | 3.65481667 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 3.63332361 |
| 25 | Anxiety (HP:0000739) | 3.54814421 |
| 26 | Focal dystonia (HP:0004373) | 3.53933483 |
| 27 | Prolonged QT interval (HP:0001657) | 3.53010982 |
| 28 | Action tremor (HP:0002345) | 3.49625216 |
| 29 | Craniofacial dystonia (HP:0012179) | 3.49114604 |
| 30 | Poor eye contact (HP:0000817) | 3.47778559 |
| 31 | Depression (HP:0000716) | 3.47748311 |
| 32 | Broad-based gait (HP:0002136) | 3.45573372 |
| 33 | Ankle clonus (HP:0011448) | 3.44685942 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 3.44482780 |
| 35 | Abnormality of macular pigmentation (HP:0008002) | 3.43609894 |
| 36 | Oligodactyly (HP:0012165) | 3.40358987 |
| 37 | Abnormal social behavior (HP:0012433) | 3.24161777 |
| 38 | Impaired social interactions (HP:0000735) | 3.24161777 |
| 39 | Scanning speech (HP:0002168) | 3.22961724 |
| 40 | Fibular aplasia (HP:0002990) | 3.21576253 |
| 41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.21455407 |
| 42 | Abnormal ciliary motility (HP:0012262) | 3.13889945 |
| 43 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.11517298 |
| 44 | Absent/shortened dynein arms (HP:0200106) | 3.11517298 |
| 45 | Abnormality of binocular vision (HP:0011514) | 3.10849341 |
| 46 | Diplopia (HP:0000651) | 3.10849341 |
| 47 | Atonic seizures (HP:0010819) | 3.09557497 |
| 48 | Truncal ataxia (HP:0002078) | 3.04671690 |
| 49 | Stereotypic behavior (HP:0000733) | 3.01210133 |
| 50 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.99814408 |
| 51 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.99814408 |
| 52 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.99352749 |
| 53 | Dysmetria (HP:0001310) | 2.92869830 |
| 54 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.90835041 |
| 55 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.90835041 |
| 56 | Abnormality of the corticospinal tract (HP:0002492) | 2.88982877 |
| 57 | Hyperventilation (HP:0002883) | 2.83401802 |
| 58 | Abnormal EKG (HP:0003115) | 2.81924113 |
| 59 | Ankyloglossia (HP:0010296) | 2.81446094 |
| 60 | Abnormal eating behavior (HP:0100738) | 2.79633571 |
| 61 | Postural instability (HP:0002172) | 2.74898394 |
| 62 | Radial bowing (HP:0002986) | 2.73320953 |
| 63 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.68859753 |
| 64 | Pointed chin (HP:0000307) | 2.68757141 |
| 65 | Mutism (HP:0002300) | 2.68457038 |
| 66 | Scotoma (HP:0000575) | 2.67774748 |
| 67 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.64007542 |
| 68 | Bowing of the arm (HP:0006488) | 2.60979771 |
| 69 | Bowed forearm bones (HP:0003956) | 2.60979771 |
| 70 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.60120247 |
| 71 | Impaired smooth pursuit (HP:0007772) | 2.55797626 |
| 72 | Urinary urgency (HP:0000012) | 2.48252109 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.47168085 |
| 74 | EEG with generalized epileptiform discharges (HP:0011198) | 2.45292185 |
| 75 | Sleep apnea (HP:0010535) | 2.42287085 |
| 76 | Lower limb amyotrophy (HP:0007210) | 2.42058770 |
| 77 | Impaired vibratory sensation (HP:0002495) | 2.40932810 |
| 78 | Broad ribs (HP:0000885) | 2.40734410 |
| 79 | Spastic gait (HP:0002064) | 2.38224578 |
| 80 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.38181796 |
| 81 | Hemiparesis (HP:0001269) | 2.37467533 |
| 82 | Incomplete penetrance (HP:0003829) | 2.31656172 |
| 83 | Ventricular fibrillation (HP:0001663) | 2.30992021 |
| 84 | Bradykinesia (HP:0002067) | 2.30561585 |
| 85 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.29315135 |
| 86 | Neurofibrillary tangles (HP:0002185) | 2.27078738 |
| 87 | Amblyopia (HP:0000646) | 2.26465670 |
| 88 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26410223 |
| 89 | Limb dystonia (HP:0002451) | 2.23391488 |
| 90 | Adactyly (HP:0009776) | 2.21788644 |
| 91 | Gait imbalance (HP:0002141) | 2.21360090 |
| 92 | Drooling (HP:0002307) | 2.19204831 |
| 93 | Excessive salivation (HP:0003781) | 2.19204831 |
| 94 | Supranuclear gaze palsy (HP:0000605) | 2.17280517 |
| 95 | Decreased central vision (HP:0007663) | 2.16335240 |
| 96 | Intention tremor (HP:0002080) | 2.16271857 |
| 97 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.15455655 |
| 98 | Genetic anticipation (HP:0003743) | 2.14394302 |
| 99 | Abnormality of the pubic bones (HP:0003172) | 2.13452096 |
| 100 | Abnormal finger flexion creases (HP:0006143) | 2.13219770 |
| 101 | Hypoplastic nipples (HP:0002557) | 2.12149344 |
| 102 | Rhinitis (HP:0012384) | 2.12070160 |
| 103 | Status epilepticus (HP:0002133) | 2.09310819 |
| 104 | Hypsarrhythmia (HP:0002521) | 2.07553043 |
| 105 | Progressive inability to walk (HP:0002505) | 2.07004354 |
| 106 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.03720728 |
| 107 | Congenital primary aphakia (HP:0007707) | 2.03134947 |
| 108 | Sudden death (HP:0001699) | 2.01607531 |
| 109 | Atrial fibrillation (HP:0005110) | 2.01543293 |
| 110 | Syncope (HP:0001279) | 2.00128709 |
| 111 | Clonus (HP:0002169) | 1.98971738 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 1.96990131 |
| 113 | Primary atrial arrhythmia (HP:0001692) | 1.96313010 |
| 114 | Abnormality of oral frenula (HP:0000190) | 1.96073510 |
| 115 | Abnormality of the lower motor neuron (HP:0002366) | 1.94361502 |
| 116 | Abnormality of saccadic eye movements (HP:0000570) | 1.94003788 |
| 117 | Fetal akinesia sequence (HP:0001989) | 1.93133970 |
| 118 | Megalencephaly (HP:0001355) | 1.92747103 |
| 119 | Bundle branch block (HP:0011710) | 1.90586550 |
| 120 | Papilledema (HP:0001085) | 1.90482996 |
| 121 | Tetraplegia (HP:0002445) | 1.87707193 |
| 122 | Absent speech (HP:0001344) | 1.87599995 |
| 123 | Septo-optic dysplasia (HP:0100842) | 1.87430229 |
| 124 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.86758694 |
| 125 | Lower limb muscle weakness (HP:0007340) | 1.86569541 |
| 126 | Hemiplegia (HP:0002301) | 1.86069630 |
| 127 | Neuronal loss in central nervous system (HP:0002529) | 1.84776143 |
| 128 | Dysphonia (HP:0001618) | 1.84058793 |
| 129 | Inability to walk (HP:0002540) | 1.83191707 |
| 130 | Medial flaring of the eyebrow (HP:0010747) | 1.82929902 |
| 131 | Supraventricular tachycardia (HP:0004755) | 1.82758204 |
| 132 | Cerebral inclusion bodies (HP:0100314) | 1.81862105 |
| 133 | Exercise-induced myalgia (HP:0003738) | 1.81395339 |
| 134 | Type II lissencephaly (HP:0007260) | 1.79730019 |
| 135 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79434193 |
| 136 | Spinal canal stenosis (HP:0003416) | 1.78907701 |
| 137 | Lower limb asymmetry (HP:0100559) | 1.77729478 |
| 138 | Polygenic inheritance (HP:0010982) | 1.75097518 |
| 139 | Gait ataxia (HP:0002066) | 1.74916694 |
| 140 | Atrioventricular block (HP:0001678) | 1.74871954 |
| 141 | Supraventricular arrhythmia (HP:0005115) | 1.74392571 |
| 142 | Deeply set eye (HP:0000490) | 1.74303108 |
| 143 | Generalized myoclonic seizures (HP:0002123) | 1.73963530 |
| 144 | Barrel-shaped chest (HP:0001552) | 1.68820401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.27876022 |
| 2 | NTRK3 | 3.76222812 |
| 3 | MAP3K9 | 3.36326624 |
| 4 | MAP3K4 | 2.75702265 |
| 5 | RIPK4 | 2.51275612 |
| 6 | MINK1 | 2.43967514 |
| 7 | KSR2 | 2.42058407 |
| 8 | CAMKK1 | 2.37586574 |
| 9 | DAPK2 | 2.35052162 |
| 10 | KSR1 | 2.27864878 |
| 11 | CAMKK2 | 2.15016736 |
| 12 | MAP3K13 | 2.03963739 |
| 13 | FES | 2.03901501 |
| 14 | SIK3 | 2.02700716 |
| 15 | ARAF | 2.00630407 |
| 16 | PAK6 | 1.98777655 |
| 17 | PRKD3 | 1.84581176 |
| 18 | MARK1 | 1.79204457 |
| 19 | TNIK | 1.71495649 |
| 20 | FGFR2 | 1.71027469 |
| 21 | MAP2K7 | 1.65708859 |
| 22 | NTRK2 | 1.61299741 |
| 23 | PRPF4B | 1.57380710 |
| 24 | CASK | 1.57302565 |
| 25 | TAOK1 | 1.56523791 |
| 26 | NTRK1 | 1.55484939 |
| 27 | LATS2 | 1.54774854 |
| 28 | CDK5 | 1.50833158 |
| 29 | SIK2 | 1.41983620 |
| 30 | SGK223 | 1.41392265 |
| 31 | SGK494 | 1.41392265 |
| 32 | PNCK | 1.33264895 |
| 33 | MAPK15 | 1.32147896 |
| 34 | NEK1 | 1.30228151 |
| 35 | SGK2 | 1.28195512 |
| 36 | DAPK1 | 1.18070261 |
| 37 | BMPR2 | 1.17046552 |
| 38 | RAF1 | 1.14947882 |
| 39 | STK38 | 1.14235142 |
| 40 | MAP3K2 | 1.13445951 |
| 41 | PINK1 | 1.12206800 |
| 42 | PAK3 | 1.11073588 |
| 43 | MAP2K4 | 1.03181620 |
| 44 | SGK3 | 1.02982538 |
| 45 | PKN1 | 0.99631289 |
| 46 | BMPR1B | 0.96532989 |
| 47 | PRKCG | 0.91377993 |
| 48 | CAMK1 | 0.89913904 |
| 49 | CDK18 | 0.89756697 |
| 50 | SGK1 | 0.88018707 |
| 51 | CAMK2A | 0.87232296 |
| 52 | TNK2 | 0.83597889 |
| 53 | CDK14 | 0.81149301 |
| 54 | PRKCH | 0.78831065 |
| 55 | CDK15 | 0.78751841 |
| 56 | TYRO3 | 0.76543506 |
| 57 | STK11 | 0.74538699 |
| 58 | DYRK1A | 0.73128598 |
| 59 | MARK2 | 0.72190873 |
| 60 | PLK2 | 0.71659809 |
| 61 | BCR | 0.71299204 |
| 62 | BRAF | 0.70818887 |
| 63 | GRK5 | 0.70536630 |
| 64 | STK16 | 0.70174633 |
| 65 | MAPK13 | 0.70027650 |
| 66 | WNK1 | 0.68472584 |
| 67 | CDK11A | 0.67875465 |
| 68 | AKT3 | 0.67597828 |
| 69 | NEK6 | 0.67571718 |
| 70 | MAPK12 | 0.66227352 |
| 71 | PIK3CA | 0.66154428 |
| 72 | CAMK2B | 0.65732589 |
| 73 | TRIB3 | 0.64065762 |
| 74 | PHKG2 | 0.63852969 |
| 75 | PHKG1 | 0.63852969 |
| 76 | MAP3K1 | 0.62916201 |
| 77 | MAP2K1 | 0.61247526 |
| 78 | PDPK1 | 0.59925348 |
| 79 | SCYL2 | 0.59693495 |
| 80 | CAMK4 | 0.59307962 |
| 81 | STK38L | 0.58657514 |
| 82 | RIPK1 | 0.58203124 |
| 83 | RPS6KA3 | 0.57465512 |
| 84 | PDK1 | 0.57331780 |
| 85 | LATS1 | 0.57225319 |
| 86 | PRKCZ | 0.56005625 |
| 87 | CAMK2D | 0.54802752 |
| 88 | PTK2B | 0.51967510 |
| 89 | NME1 | 0.51670886 |
| 90 | PRKCE | 0.49801855 |
| 91 | ERBB2 | 0.49735390 |
| 92 | RET | 0.49548778 |
| 93 | UHMK1 | 0.49069850 |
| 94 | MOS | 0.48833382 |
| 95 | MAPK10 | 0.48043597 |
| 96 | IRAK2 | 0.47977940 |
| 97 | FYN | 0.47726426 |
| 98 | OBSCN | 0.47096267 |
| 99 | PRKG1 | 0.46469198 |
| 100 | FER | 0.44814345 |
| 101 | PRKCQ | 0.44572626 |
| 102 | RPS6KB1 | 0.44501699 |
| 103 | TESK1 | 0.43782948 |
| 104 | LIMK1 | 0.42835437 |
| 105 | PRKACA | 0.42346066 |
| 106 | PRKD2 | 0.41499216 |
| 107 | WNK4 | 0.40767897 |
| 108 | * PRKCB | 0.40619968 |
| 109 | TAOK2 | 0.40198370 |
| 110 | PRKCI | 0.39359469 |
| 111 | ROCK1 | 0.38851144 |
| 112 | MET | 0.38818313 |
| 113 | MAP3K12 | 0.37312901 |
| 114 | ADRBK2 | 0.37295630 |
| 115 | TSSK6 | 0.37249715 |
| 116 | STK39 | 0.36603534 |
| 117 | CDK19 | 0.36283270 |
| 118 | WNK3 | 0.34504677 |
| 119 | MUSK | 0.34470501 |
| 120 | CSNK1G2 | 0.34221627 |
| 121 | PRKACG | 0.33669462 |
| 122 | PRKCA | 0.33531644 |
| 123 | MAP3K7 | 0.33254414 |
| 124 | DAPK3 | 0.32718690 |
| 125 | CSNK1A1 | 0.30733608 |
| 126 | CAMK2G | 0.30331405 |
| 127 | MAPK8 | 0.29628484 |
| 128 | CDK3 | 0.28206994 |
| 129 | OXSR1 | 0.26525591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.73614025 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.51610150 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.26137017 |
| 4 | * Morphine addiction_Homo sapiens_hsa05032 | 3.17975812 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.15979812 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.90472618 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.83071580 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47317887 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36870913 |
| 10 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.34282082 |
| 11 | Renin secretion_Homo sapiens_hsa04924 | 2.30902821 |
| 12 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.29709920 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.25457303 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.20727753 |
| 15 | * Cocaine addiction_Homo sapiens_hsa05030 | 2.10080920 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94021161 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.91295039 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.91253546 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.85680927 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.83964180 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.69539181 |
| 22 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67276511 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66717397 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58331689 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.57059033 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.50573715 |
| 27 | * Gap junction_Homo sapiens_hsa04540 | 1.35551311 |
| 28 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.34559219 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33965926 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29842482 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21620372 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19168366 |
| 33 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17438234 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16512147 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.14803986 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14772780 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03459324 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99616417 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97348436 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95075746 |
| 41 | Glioma_Homo sapiens_hsa05214 | 0.93572696 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91673291 |
| 43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86909239 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84707106 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82065022 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81036592 |
| 47 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.79780756 |
| 48 | * Alcoholism_Homo sapiens_hsa05034 | 0.78986407 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78158322 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77581354 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77515455 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76277862 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.75938956 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74546111 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74489953 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73843048 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73312743 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73205140 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68854218 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68066453 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.67910001 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65144229 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64134600 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64021971 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63198558 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63195536 |
| 67 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62780026 |
| 68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62745690 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61039810 |
| 70 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.60330830 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58576691 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51807728 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51558475 |
| 74 | Tight junction_Homo sapiens_hsa04530 | 0.51280855 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50740189 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50412332 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50111165 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49927941 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49604785 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49195499 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48389117 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46130941 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46018277 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45380476 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44304610 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42033011 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41540858 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.40693859 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40550359 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39949199 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39191371 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36937028 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35411857 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33709673 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33699733 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31651679 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30724167 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.30485686 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29182970 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29130644 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28544643 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28374220 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.27848219 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27748180 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25934253 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25841030 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.25701857 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.25151199 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24903999 |
| 110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24223131 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20273726 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19757421 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18904723 |
| 114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.18822467 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.18564306 |
| 116 | Parkinsons disease_Homo sapiens_hsa05012 | 0.18332648 |
| 117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.16683367 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15968083 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14436624 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.14149970 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13753390 |

